GENE ONLINE|News &
Opinion
Blog

Merck
Trials & Approvals Lung Cancer
Japan Approves World’s First Therapy for Metastatic Non–Small Cell Lung Cancer with METex14
2020-03-26
COVID-19 Virus Suppressing Factor
Weekly Cover: Takeda Initiates Development of Potential COVID-19 Therapy TAK-888
2020-03-13
R&D Classical Hodgkin Lymphoma
Keytruda Outcompetes Adcetris in Refractory or Relapsed Hodgkin Lymphoma Study
2020-03-03
Trials & Approvals Breast Cancer
Yet Another Feather in Merck’s Crown, Keytruda Meets Endpoint in Phase 3 Trial for Triple Negative Breast Cancer
2020-02-13
Ranking & Reports
GeneOnline’s Top Mergers and Acquisitions of 2019
2019-12-31
Weekly in Asia 2019｜JUL
2019-08-02
sNDA
Weekly in Asia 2019｜JULY
2019-07-11
M&A Immune Design
Merck set to acquire Tilos Therapeutics for $773 million
2019-06-12
Gene Therapy
Weekly Top 5 in China (0317-0323)
2019-03-25
Ranking & Reports Active Pharmaceutical Ingredient
Weekly Top 5 in China (0217-0223)
2019-02-22
Trials & Approvals Ovarian Cancer
First PARP inhibitor approved for 1L maintenance therapy of BRCAm advanced ovarian cancer
2018-12-28
Trials & Approvals
European approval of Pembrolizumab for resected Stage III melanoma – KN-54 excerpts
2018-12-21
AI
2018 MEDTEX Summit: CEO Perspectives
2018-12-06Partner
Trials & Approvals Alanine Aminotransferase
Expedited Approval of Vitrakvi® Marks Many Firsts in Cancer Therapy
2018-12-04
Asia-Pacific
Med X Tech Summit Asia (MEDTEX) 2018 – Overview of Day 1 Program
2018-11-22Partner
1 … 4 5 6 7
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top